Dallas-based MedCAD has received 510 (k) FDA clearance for its AccuStride fixation plates.
The plates are part of the company’s complete foot and ankle system, which is designed to be used for revision procedures, deformities, arthritic or diabetic conditions and trauma-related foot and ankle injuries, according to a Nov. 6 news release from MedCAD.
Components of the AccuStride system are made out of UV-curable acrylate polymers or titanium alloy materials.
The company earned FDA clearance for the system’s guides and planning system in March 2025, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.